These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 35187614)

  • 1. Barriers and Enablers of Healthcare Providers to Deprescribe Cardiometabolic Medication in Older Patients: A Focus Group Study.
    Abou J; Crutzen S; Tromp V; Heringa M; Van Marum R; Elders P; Taxis K; Denig P; Hugtenburg J
    Drugs Aging; 2022 Mar; 39(3):209-221. PubMed ID: 35187614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deprescribing Potentially Inappropriate Preventive Cardiovascular Medication: Barriers and Enablers for Patients and General Practitioners.
    Luymes CH; van der Kleij RM; Poortvliet RK; de Ruijter W; Reis R; Numans ME
    Ann Pharmacother; 2016 Jun; 50(6):446-54. PubMed ID: 26939589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a hospital deprescribing implementation framework: A focus group study with geriatricians and pharmacists.
    Scott S; Twigg MJ; Clark A; Farrow C; May H; Patel M; Taylor J; Wright DJ; Bhattacharya D
    Age Ageing; 2019 Dec; 49(1):102-110. PubMed ID: 31711097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a multicomponent communication training to involve older people in decisions to DEPRESCRIBE cardiometabolic medication in primary care (CO-DEPRESCRIBE): protocol for a cluster randomized controlled trial with embedded process and economic evaluation.
    Stuijt PJC; Heringa M; van Dijk L; Faber A; Burgers JS; Feenstra TL; Taxis K; Denig P
    BMC Prim Care; 2024 Jun; 25(1):210. PubMed ID: 38862899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers and enablers to deprescribing in long-term care: A qualitative investigation into the opinions of healthcare professionals in Ireland.
    Heinrich CH; McHugh S; McCarthy S; Donovan MD
    PLoS One; 2022; 17(12):e0274552. PubMed ID: 36520798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barriers and enablers to deprescribing for older people in care homes: The theory-based perspectives of pharmacist independent prescribers.
    Alharthi M; Wright D; Scott S; Birt L
    Res Social Adm Pharm; 2023 May; 19(5):746-752. PubMed ID: 36732210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Professional roles of general practitioners, community pharmacists and specialist providers in collaborative medication deprescribing - a qualitative study.
    Gerlach N; Michiels-Corsten M; Viniol A; Schleef T; Junius-Walker U; Krause O; Donner-Banzhoff N
    BMC Fam Pract; 2020 Sep; 21(1):183. PubMed ID: 32887551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barriers and enablers for deprescribing benzodiazepine receptor agonists in older adults: a systematic review of qualitative and quantitative studies using the theoretical domains framework.
    Evrard P; Pétein C; Beuscart JB; Spinewine A
    Implement Sci; 2022 Jul; 17(1):41. PubMed ID: 35804428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unlocking Deprescribing Potential in Nursing Homes: Insights from a Focus Group Study with Healthcare Professionals.
    Visser AGR; de-Bruijn JBGP; Spaetgens B; Winkens B; Janknegt R; Schols JMGA
    Drugs Aging; 2024 Mar; 41(3):261-270. PubMed ID: 38285238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health Care Practitioners' Perspectives on Deprescribing Anticholinergic and Sedative Medications in Older Adults.
    Kouladjian L; Gnjidic D; Reeve E; Chen TF; Hilmer SN
    Ann Pharmacother; 2016 Aug; 50(8):625-36. PubMed ID: 27257284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicians' views on pharmacists' involvement in hospital deprescribing: A qualitative study on proton pump inhibitors.
    Gendre P; Mayol S; Mocquard J; Huon JF
    Basic Clin Pharmacol Toxicol; 2023 Dec; 133(6):718-728. PubMed ID: 37081726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Considerations, barriers and enablers of deprescribing among healthcare professionals in Ogun State, Southwest, Nigeria: a cross-sectional survey.
    Saka SA; Osineye TR
    BMC Health Serv Res; 2024 May; 24(1):661. PubMed ID: 38789975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacists' attitudes towards interprofessional collaboration to optimise medication use in older patients in Switzerland: a survey study.
    Lüthold RV; Cateau D; Jenkinson SP; Streit S; Jungo KT
    BMC Health Serv Res; 2024 Jul; 24(1):849. PubMed ID: 39061037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers and Enablers of Older Patients to Deprescribing of Cardiometabolic Medication: A Focus Group Study.
    Crutzen S; Baas G; Abou J; van den Born-Bondt T; Hugtenburg JG; Bouvy ML; Heringa M; Taxis K; Denig P
    Front Pharmacol; 2020; 11():1268. PubMed ID: 32973509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barriers and enablers towards benzodiazepine-receptor agonists deprescribing in nursing homes: A qualitative study of stakeholder groups.
    Evrard P; Damiaens A; Patey AM; Grimshaw JM; Spinewine A
    Explor Res Clin Soc Pharm; 2023 Mar; 9():100258. PubMed ID: 37124470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges and Enablers of Deprescribing: A General Practitioner Perspective.
    Ailabouni NJ; Nishtala PS; Mangin D; Tordoff JM
    PLoS One; 2016; 11(4):e0151066. PubMed ID: 27093289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-design of a behaviour change intervention to equip geriatricians and pharmacists to proactively deprescribe medicines that are no longer needed or are risky to continue in hospital.
    Scott S; Atkins B; Kellar I; Taylor J; Keevil V; Alldred DP; Murphy K; Patel M; Witham MD; Wright D; Bhattacharya D
    Res Social Adm Pharm; 2023 May; 19(5):707-716. PubMed ID: 36841632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge and willingness of physicians about deprescribing among older patients: a qualitative study.
    AlRasheed MM; Alhawassi TM; Alanazi A; Aloudah N; Khurshid F; Alsultan M
    Clin Interv Aging; 2018; 13():1401-1408. PubMed ID: 30122912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Barriers and enablers of older adults initiating a deprescribing conversation.
    Ailabouni NJ; Rebecca Weir K; Reeve E; Turner JT; Wilson Norton J; Gray SL
    Patient Educ Couns; 2022 Mar; 105(3):615-624. PubMed ID: 34183219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barriers and enablers to monitoring and deprescribing opioid analgesics for chronic non-cancer pain: a systematic review with qualitative evidence synthesis using the Theoretical Domains Framework.
    Cross AJ; Buchbinder R; Mathieson S; Bourne A; Maher CG; Lin CC; O'Connor DA
    BMJ Qual Saf; 2022 May; 31(5):387-400. PubMed ID: 35064054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.